FDA - Food and Drug Administration Archives - Consumer Justice Foundation

Category: FDA – Food and Drug Administration

FDA Calls for Immediate Removal of All Zantac, Ranitidine Products from the Market

April 2, 2020

The U.S. Food and Drug Administration (FDA) announced this week that it is asking manufacturers of Zantac and generic ranitidine products to withdraw all prescription and over-the-counter (OTC) versions of the drug from the market immediately. The FDA’s decision is the latest step in an ongoing investigation into the presence of… Read More> Comments Off on FDA Calls for Immediate Removal of All Zantac, Ranitidine Products from the Market

Asbestos Contamination Concerns Prompt Government Experts to Urge New Talc Testing Standards

January 15, 2020

A panel of experts convened by the U.S. Food and Drug Administration (FDA) is calling for the implementation of new testing standards and safety parameters for talc-based products, amid concerns about the potential for these products to be contaminated with asbestos and expose users to a risk of cancer. The recommendations,… Read More> Comments Off on Asbestos Contamination Concerns Prompt Government Experts to Urge New Talc Testing Standards

Nuplazid Patient Deaths

April 14, 2018

Reports of Deaths Linked to Parkinson’s Disease Psychosis Drug Spark Safety Concerns

Hundreds of patients have died while taking Nuplazid, a drug manufactured by San Diego-based Acadia Pharmaceuticals to control psychosis related to Parkinson’s disease, a debilitating movement disorder that affects hundreds of thousands of individuals and has a typical…

Read More> Comments Off on Nuplazid Patient Deaths

Essure Black Box Warning

March 2, 2016

FDA Requires New Black Box Warning on Essure Contraceptive Label

After more than 5,000 women have filed adverse event reports with the U.S. Food and Drug Administration (FDA) alleging devastating complications from Essure, the FDA is finally requiring a new “black box” warning for the permanent contraceptive device to “call…

Read More> Comments Off on Essure Black Box Warning

Vaginal Mesh a High-Risk Device

January 5, 2016

FDA Issues High-Risk Warning for Transvaginal Mesh Devices

The U.S. Food and Drug Administration (FDA) has finally responded to calls for stronger warnings on the use of transvaginal mesh, reclassifying mesh devices marketed for the transvaginal repair of pelvic organ prolapse (POP) as class III high-risk devices. According to its…

Read More> Comments Off on Vaginal Mesh a High-Risk Device

Chantix Seizure Warnings

March 11, 2015

FDA Adds New Warnings to Chantix Label Regarding Seizures, Alcohol Effects

People taking Chantix to quit smoking may be at risk for seizures, alcohol intolerance and other serious side effects.

Despite recent efforts by Pfizer to reduce warning requirements for its smoking cessation drug Chantix, the FDA announced this week that…

Read More> Comments Off on Chantix Seizure Warnings

New Testosterone Therapy Warnings

March 5, 2015

FDA Adds New Heart Attack, Stroke Warnings to Testosterone Drugs

New FDA warnings must be added to the labels of low-T drugs that include the risk of side effects like heart attack, stroke and sudden death.

Federal drug regulators are requiring stronger warnings regarding the potential risk of side effects like…

Read More> Comments Off on New Testosterone Therapy Warnings
Start Claim Now
Do you deserve compensation?

An attorney will review your situation for FREE and help you found out what really went wrong.

How Can We Reach You?

Please Explain Your Situation

By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.
×